Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Debt Ratio (2017 - 2026)

Tilray Brands' (TLRY) quarterly Debt Ratio came in at 0.06 in Q2 2026, down 24.47% YoY from 0.08 in Q2 2025, and down 18.98% on a QoQ basis from 0.07 in Q1 2026.

Tilray Brands (TLRY) Debt Ratio (2017 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 10 years of Debt Ratio data on file, last reported at 0.06 in Q2 2026.

  • Quarterly Debt Ratio fell 24.47% year-over-year to 0.06 in Q2 2026, while the trailing twelve-month figure through May 2026 was 0.06 (down 24.47% YoY) and the FY2026 annual result came in at 0.06, down 24.47% from the prior year.
  • Debt Ratio retreated to 0.06 in Q2 2026, from 0.07 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.09 in Q3 2023 to a low of 0.03 in Q3 2022.
  • A 5-year average of 0.06 and a median of 0.06 in 2022 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2023 — Debt Ratio soared 187.68% — and 2024, when it slumped 55.66%.
  • Tracing TLRY's Debt Ratio over 5 years: stood at 0.06 in 2022, then rose by 12.71% to 0.07 in 2023, then sank by 42.14% to 0.04 in 2024, then surged by 86.56% to 0.07 in 2025, then decreased by 19.73% to 0.06 in 2026.
  • The last three Debt Ratio figures came in at 0.06 (Q2 2026), 0.07 (Q1 2026), and 0.07 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -0.13
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 0.42
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 0.60
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.32
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn -
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 0.38
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.29
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 0.12
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn 0.06

Historic Data

Download Data
DateValue
May 31, 2026 0.06
Feb 28, 2026 0.07
Nov 30, 2025 0.07
Aug 31, 2025 0.08
May 31, 2025 0.08
Nov 30, 2024 0.04
Aug 31, 2024 0.04
May 31, 2024 0.04
Feb 29, 2024 0.06
Nov 30, 2023 0.07
Aug 31, 2023 0.09
May 31, 2023 0.07
Feb 28, 2023 0.06
Nov 30, 2022 0.06
Aug 31, 2022 0.03
May 31, 2022 0.03
Feb 28, 2022 0.03
Nov 30, 2021 0.04
Aug 31, 2021 0.04
May 31, 2021 0.04